4//SEC Filing
ImmunoCellular Therapeutics, Ltd. 4
Accession 0001181431-13-060956
$IMUCCIK 0000822411operating
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 8:44 PM ET
Size
11.8 KB
Accession
0001181431-13-060956
Insider Transaction Report
Form 4
Yu John S
DirectorSecretary
Transactions
- Exercise/Conversion
Common Stock
2013-11-25$0.25/sh+32,613$8,153→ 42,613 total - Gift
Common Stock
2013-11-25−32,613→ 10,000 total - Gift
Common Stock
2013-11-25+32,613→ 32,613 total(indirect: By Trust) - Sale
Common Stock
2013-10-18$2.85/sh−32,613$92,875→ 0 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2013-11-25−32,613→ 0 totalExercise: $0.25Exp: 2014-02-25→ Common Stock (32,613 underlying)
Footnotes (4)
- [F1]These shares are being transferred to the reporting person's Family Trust.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported is an average price. The prices ranged from $2.8000 to $3.0300 per share. Full information regarding the number of shares sold at each separate price within the range set forth in this footnote is available upon request by the SEC, the issuer or a security holder of the issuer.
- [F4]Fully vested.
Documents
Issuer
ImmunoCellular Therapeutics, Ltd.
CIK 0000822411
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000822411
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 8:44 PM ET
- Size
- 11.8 KB